JRJhon Erick Rivera-Monroy

Jhon Erick Rivera-Monroy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jhon Erick Rivera-Monroy has a total of 96 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Monomeric and Dimeric Lactoferricin B Derivatives as Potent Agents against Multidrug-Resistant Clinical Isolates of Staphylococcus aureus

    by Kelin Johana Cuero-Amu, Juan Esteban Reyes-Calderón, Jose David Mendoza-Mendoza, Dennis Santiago Franco-Zambrano, Aura Lucía Leal-Castro, Jhon Erick Rivera-Monroy, Zuly Jenny Rivera-Monroy, Javier Eduardo García-CastañeDa

    Staphylococcus aureus is exhibiting an increase in antimicrobial resistance, which represents a global challenge to public health and requires the urgent development of new therapies, with synthetic peptides being a viable and novel alternative. In this investigation, high-purity monomeric and dimeric synthetic peptides derived from bovine lactoferricin were produced. These antimicrobial peptides did not affect human erythrocytes, nor did they have antagonistic effects with vancomycin and oxacillin. Bacteria treated with sublethal peptide concentrations for a long time did not develop tolerance to the evaluated peptides. The results demonstrated that dimeric peptides are more potent than their monomeric analogs, particularly peptide (RRWQWR-Nal-KKLG)2-K-Ahx, which stood out as the most promising candidate, displaying an MIC of 15 μM in both the reference strain and clinical isolates resistant to penicillin, erythromycin, tetracycline, and MRSA. SEM analysis indicated that the antibacterial activity of the peptide may cause disruption of the cell wall and/or cytoplasmic membrane and loss of intracellular contents. We concluded that the dimeric peptides evaluated showed potent and selective effects in Staphylococcus aureus strains, suggesting that these molecules could be considered as candidates for evaluation as possible therapeutic tools for combating infections caused by S. aureus.

  • Open Access

    A Lactoferricin B/Buforin Chimeric Peptide Causes a Rapid, Selective, Prolonged Cytotoxic Effect and Induces Apoptosis in HPV18-Positive Cervical Cancer Cells

    by Natalia Ardila-Chantré, Andrea Carolina Barragán-Cárdenas, Juan Esteban Reyes-Calderón, Dennis Santiago Franco-Zambrano, Edwar Alejandro Matta-Orjuela, Jhon Erick Rivera-Monroy, Emma Muñoz-Sáez, Claudia Carabaña-García, Claudia Marcela Parra-Giraldo, Ricardo Fierro-Medina, et al.

    This study focuses on the chimeric peptide KKWQWK-Ahx-RLLRRLLR and its interaction with cancer cells, specifically HPV18-positive cervical cancer HeLa and Ca Ski cells. The main objective of this study was to understand the mode of action of this chimera related to its cytotoxic activity, as well as the internalization processes and the type of cell death induced. For this purpose, several in vitro and in vivo assays were performed, showing that the uptake of the chimera is not energy-dependent and could involve a passive transport process. The results suggested that chimera internalization can be mediated by a specific interaction of the peptide with molecules on the cell membrane. The cytotoxic effect of the chimera in cervical cancer cells causes severe morphological changes, including rounding, shrinking, and vacuole formation. It was also determined that the chimera primarily induces early and late apoptosis in HeLa cells, without causing necrosis, and activates caspases 3 and 7. The chimera was localized in both the cytoplasm and the nucleus of the cancer cells, suggesting that the peptide could interact with intracellular targets. In conclusion, this study provides a broader understanding of the mechanism of action of the KKWQWK-Ahx-RLLRRLLR chimera on cancer cells, highlighting its ability to induce a fast, selective, and significantly cytotoxic effect in cervical cancer cells, which involves cell death through the apoptotic pathway. The toxicity assays in Galleria mellonella and zebra fish showed that the chimera is safe and can be considered for preclinical studies. This study demonstrated that the chemical binding of two sequences with low activity produces a chimeric entity with enhanced cytotoxic activity capable of cellular internalization and inducement of apoptosis.


  • How to Improve the RRWQWR Anticancer Activity? Strategy I: Chimera Building

    by Natalia Ardila‐Chantré, Yerly Vargas‐Casanova, Andrea Carolina Barragán‐Cárdenas, Dennis Santiago Franco‐Zambrano, Jhon Erick Rivera‐Monroy, Claudia Marcela Parra‐Giraldo, Ricardo Fierro‐Medina, Zuly Jenny Rivera‐Monroy, Javier Eduardo García‐Castañeda

    Cervical cancer currently affects thousands of women worldwide. Consequently, the search for new peptide molecules, particularly chimeric peptides, has been proposed to treat this disease. In the present study, a library of chimeric peptides containing the RRWQWR sequence conjugated to functional peptides (such as anticancer peptides, cervical cancer cell‐targeting peptides, and cell‐penetrating peptides) was designed and synthesized. The most active chimera was optimized through chemical modifications, including the replacement of Arg with Lys, formation of dimers, changes in the linker, and deletion of amino acids at the N‐ and/or C‐terminus. All chimeric peptides were obtained via solid‐phase peptide synthesis and characterized by means of RP‐HPLC and mass spectrometry. The cytotoxicity of the chimeras against human cervical cancer cell lines HeLa and Ca Ski was evaluated in vitro. The results demonstrated that it is possible to obtain chimeric peptides from the RRWQWR core conjugated with functional peptides. Some peptides exhibited significant cytotoxic activity against the evaluated cell lines, demonstrating selectivity, rapid action, and concentration dependence. The chimeric peptide library allowed the identification of promising chimeric peptides such as KKWQWK‐Ahx‐RLLRRLLR. The identification of molecules with anticancer activity from sequences with lower activity represents a rapid, cost‐effective, and highly accurate strategy.


  • Open Access

    Fluorescent Peptides Internalize HeLa Cells and Kill Multidrug-Resistant Clinical Bacterial Isolates

    by Daniel Castellar-Almonacid, Kelin Johana Cuero-Amu, Jose David Mendoza-Mendoza, Natalia Ardila-Chantré, Fernando José Chavez-Salazar, Andrea Carolina Barragán-Cárdenas, Jhon Erick Rivera-Monroy, Claudia Parra-Giraldo, Zuly Jenny Rivera-Monroy, Javier García-Castañeda, et al.

    Palindromic antimicrobial peptides (PAMs) constitute versatile scaffolds for the design and optimization of anticancer agents with applications in therapy, diagnosis, and/or monitoring. In the present study, fluorolabeled peptides derived from the palindromic sequence RWQWRWQWR containing fluorescent probes, such as 2-Aminobenzoyl, 5(6)-Carboxyfluorescein, and Rhodamine B, were obtained. RP-HPLC analysis revealed that the palindromic peptide conjugated to Rhodamine B (RhB-RWQWRWQWR) exhibited the presence of isomers, likely corresponding to the open-ring and spiro-lactam forms of the fluorescent probe. This equilibrium is dependent on the peptide sequence, as the RP-HPLC analysis of dimeric peptide (RhB-RRWQWR-hF-KKLG)2K-Ahx did not reveal the presence of isomers. The antibacterial activity of the fluorescent peptides depends on the probe attached to the sequence and the bacterial strain tested. Notably, some fluorescent peptides showed activity against reference strains as well as sensitive, resistant, and multidrug-resistant clinical isolates of E. coli, S. aureus, and E. faecalis. Fluorolabeled peptides 1-Abz (MIC = 62 µM), RhB-1 (MIC = 62 µM), and Abz-1 (MIC = 31 µM) exhibited significant activity against clinical isolates of E. coli, S. aureus, and E. faecalis, respectively. The RhB-1 (IC50 = 61 µM), Abz-1 (IC50 = 87 µM), and RhB-2 (IC50 = 35 µM) peptides exhibited a rapid, significant, and concentration-dependent cytotoxic effect on HeLa cells, accompanied by morphological changes characteristic of apoptosis. RhB-1 (IC50 = 18 µM) peptide also exhibited significant cytotoxic activity against breast cancer cells MCF-7. These conjugates remain valuable for elucidating the possible mechanisms of action of these novel anticancer peptides. Rhodamine-labeled peptides displayed cytotoxicity comparable to that of their unlabeled analogues, suggesting that cellular internalization constitutes a critical early step in their mechanism of action. These findings suggest that cell death induced by both unlabeled and fluorolabeled peptides proceeds predominantly via apoptosis and is likely contingent upon peptide internalization. Functionalization at the N-terminal end of the palindromic sequence can be evaluated to develop systems for transporting non-protein molecules into cancer cells.


  • Non-steroidal anti-inflammatory drugs conjugated to a synthetic peptide exhibit in vitro cytotoxic activity against cervical cancer and melanoma cells

    by Daniel Alejandro Castellar-Almonacid, Andrea Carolina Barragán-Cárdenas, Karla Geraldine Rodríguez-Mejia, Laura Angélica Maldonado-Sanabria, Natalia Ardila-Chantré, Jose David Mendoza-Mendoza, Claudia Marcela Parra-Giraldo, Jhon Erick Rivera-Monroy, Zuly Jenny Rivera-Monroy, Javier Eduardo García-Castañeda, et al.

    Previous studies show that the palindromic peptide RWQWRWQWR, derived from bovine lactoferricin (LfcinB), exhibits selective in vitro cytotoxicity against cervical, breast, and prostate cancer cells.


  • Open Access

    Exploring New Biomarkers for Detecting Whey Adulteration in Milk: Synthesis and Characterization of Caseinomacropeptide-Derived Peptides

    by David Alexander Parada-Suárez, Jose David Mendoza-Mendoza, Kevin Andrey Huertas-Ortiz, Juan Esteban Reyes-Calderón, Jhon Erick Rivera-Monroy, Ricardo Fierro-Medina, Javier Eduardo García-Castañeda, Zuly Jenny Rivera-Monroy

    Whey adulteration in milk is a widespread issue that often escapes detection by conventional methods due to its similar composition and minimal impact on milk’s sensory characteristics. This study addresses this challenge by evaluating synthetic peptides derived from caseinomacropeptide (CMP) as potential in-house standards for detecting whey adulteration in milk using LC–MS. Two principal peptides, MAIPPKKNQDKTEIPTINT (CMP-1), derived from pepsin digestion of CMP, and TEIPTINT (CMP-3), obtained through a double digestion with pepsin followed by trypsin, were synthesized, purified, and comprehensively characterized to assess their viability as biomarkers. Isomerism in CMP-1 was initially observed through LC–MS and confirmed as cis–trans proline–proline isomerism by 2D-NMR analyses (TOCSY and ROESY), which complicates its application as a standard. Consequently, CMP-3, an isomerism-free derivative, was synthesized and demonstrated stability in both pepsin and trypsin digestions. The use of three surrogates for quantifying CMP was evaluated: CMP, CMP-1, and CMP-3, for both nonadulterated and adulterated milk samples, which allowed for effective detection and quantification of whey adulteration. Calibration curves for CMP-1 and CMP-3 were generated on high-resolution (LC–HRMS) and low-resolution (LC–LRMS) mass spectrometers, yielding R 2 values between 0.91 and 0.99. The calibration curves displayed adequate linearity, and variability in ionization efficiency underscored the need for an internal standard to ensure greater reproducibility. CMP-3 is proposed as a promising biomarker and/or in-house standard for quantifying whey adulteration in milk, offering a reliable and reproducible approach for routine LC–MS analysis.


  • Open Access

    Hybrid peptides inspired by the RWQWRWQWR sequence inhibit cervical cancer cells growth in vitro

    by Natalia Ardila-Chantré, Claudia Marcela Parra-Giraldo, Yerly Vargas-Casanova, Andrea Carolina Barragán-Cardenas, Ricardo Fierro-Medina, Zuly Jenny Rivera-Monroy, Jhon Erick Rivera-Monroy, Javier Eduardo García-Castañeda

    Aim: The aim of this research was to generate new peptide molecules with cytotoxic activity against cervical cancer that can become effective in mitigating the impact of the disease and preventing its progression. The design is based on the hybrid peptide formation strategy that allows new chemical entities to be obtained from the union of fragments of different bioactive peptides. Specifically, we worked by combining the RWQWRWQWR sequence derived from bovine lactoferricin with different functional peptides such as anticancer peptides, cervical cancer cell-targeting peptides, and cell-penetrating peptides. Methods: Hybrid peptides and precursors were synthesized by solid-phase peptide synthesis using the Fmoc/tBu strategy, purified via reverse phase (RP)-solid phase extraction, and characterized by RP-high performance liquid chromatography (RP-HPLC) chromatography and mass spectrometry. In vitro cytotoxicity of hybrid peptides in human cervical cancer cells lines HeLa and Ca Ski was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Results: All hybrid peptides were obtained with high purity and the experimental mass corresponds with the theoretical mass. Some hybrid peptides exhibited significant, fast, and selective cytotoxic activity against the cancerous cells evaluated, specifically those containing sequences of anticancer peptides and cell-penetrating peptides. The cytotoxic effect exerted by the monomeric and dimeric hybrid peptides depended on the concentration of the peptide, which allowed the determination of the IC50 values and the selectivity index (SI). Conclusions: We obtained hybrid peptides with the core sequence RWQWRWQWR that are active against HeLa and Ca Ski cell lines. The combination of the RWQWRWQWR sequence with short anticancer peptides and cell-penetrating peptides allowed the creation of hybrid peptides with improved cytotoxic potency against cervical cancer. Hybrid peptides constitute a novel, viable, and useful strategy for the design and identification of peptide drugs with anticancer activity.


  • Open Access

    Endoplasmic reticulum membrane receptors of the GET pathway are conserved throughout eukaryotes

    by Lisa Yasmin Asseck, Dietmar Gerald Mehlhorn, Jhon Rivera Monroy, Martiniano Maria Ricardi, Holger Breuninger, Niklas Wallmeroth, Kenneth Wayne Berendzen, Minou Nowrousian, Shuping Xing, Blanche Schwappach, et al.

    Significance: The GET pathway is required for the insertion of tail-anchored (TA) membrane proteins in the endoplasmic reticulum (ER) of yeast and mammals. Some orthologous genes had also been identified in higher plants with the exception of one of the two ER membrane receptors required for membrane insertion. Get2/CAML is required for the pathway’s cytosolic chaperone to dock and release its TA protein cargo. Here we report the identification of the elusive plant GET pathway receptor through an interaction screen inArabidopsis. The candidate allows detection of further Get2/CAML orthologs in higher plants, revealing conservation and function of structural features across kingdoms. Additionally, our results demonstrate that these features, rather than sequence conservation, determine functionality of the candidate within the pathway.


  • Open Access

    The Molecular Basis and Biologic Significance of the β-Dystroglycan-Emerin Interaction

    by Wendy Lilián Gómez-Monsivais, Feliciano Monterrubio-Ledezma, Jazmin Huerta-Cantillo, Ricardo Mondragon-Gonzalez, Alma Alamillo-Iniesta, Ian García-Aguirre, Paulina Margarita Azuara-Medina, Raúl Arguello-García, Jhon Erick Rivera-Monroy, James M. Holaska, et al.

    β-dystroglycan (β-DG) assembles with lamins A/C and B1 and emerin at the nuclear envelope (NE) to maintain proper nuclear architecture and function. To provide insight into the nuclear function of β-DG, we characterized the interaction between β-DG and emerin at the molecular level. Emerin is a major NE protein that regulates multiple nuclear processes and whose deficiency results in Emery–Dreifuss muscular dystrophy (EDMD). Using truncated variants of β-DG and emerin, via a series of in vitro and in vivo binding experiments and a tailored computational analysis, we determined that the β-DG–emerin interaction is mediated at least in part by their respective transmembrane domains (TM). Using surface plasmon resonance assays we showed that emerin binds to β-DG with high affinity (KD in the nanomolar range). Remarkably, the analysis of cells in which DG was knocked out demonstrated that loss of β-DG resulted in a decreased emerin stability and impairment of emerin-mediated processes. β-DG and emerin are reciprocally required for their optimal targeting within the NE, as shown by immunofluorescence, western blotting and immunoprecipitation assays using emerin variants with mutations in the TM domain and B-lymphocytes of a patient with EDMD. In summary, we demonstrated that β-DG plays a role as an emerin interacting partner modulating its stability and function.


  • Open Access

    A trap mutant reveals the physiological client spectrum of TRC40

    by Javier Coy-Vergara, Jhon Rivera-Monroy, Henning Urlaub, Christof Lenz, Blanche Schwappach

    The transmembrane recognition complex (TRC) pathway targets tail-anchored (TA) proteins to the membrane of the endoplasmic reticulum (ER). While many TA proteins are known to be able to use this pathway, it is essential for the targeting of only a few. Here, we uncover a large number of TA proteins that engage with TRC40 when other targeting machineries are fully operational. We use a dominant-negative ATPase-impaired mutant of TRC40 in which aspartate 74 was replaced by a glutamate residue to trap TA proteins in the cytoplasm. Manipulation of the hydrophobic TA-binding groove in TRC40 (also known as ASNA1) reduces interaction with most, but not all, substrates suggesting that co-purification may also reflect interactions unrelated to precursor protein targeting. We confirm known TRC40 substrates and identify many additional TA proteins interacting with TRC40. By using the trap approach in combination with quantitative mass spectrometry, we show that Golgi-resident TA proteins such as the golgins golgin-84, CASP and giantin as well as the vesicle-associated membrane-protein-associated proteins VAPA and VAPB interact with TRC40. Thus, our results provide new avenues to assess the essential role of TRC40 in metazoan organisms. This article has an associated First Person interview with the first author of the paper.